(Q28202650)

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Immunoglobulin G, total and subclass, in children with or without recurrent otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Plasma IgG, IgG subclasses and acute-phase proteins in children with recurrent acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal antibodies in families with recurrent otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal serum antibody concentrations during the first three years of life: a study of otitis-prone and non-otitis-prone children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Immunoglobulin Isotype-Specific Antibody Responses to Pneumococcal Polysaccharide Vaccine in Patients with Recurrent Bacterial Respiratory Tract Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Role of nasopharyngeal bacterial flora in the evaluation of recurrent middle ear infections in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Ontogeny of the immune response as a basis of childhood disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal Middle Ear Fluid Antibodies after Pneumococcal Acute Otitis Media in Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Secretory Antibodies Specific to Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in Middle Ear Effusion during Acute Otitis Media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Infant B cell responses to polysaccharide determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal vaccine and otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Prevention of otitis media in children by pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing Acute Otitis Media in Infants in Huntsville, Alabama

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Clinical Studies of Pneumococcal Vaccines in Infants. II. Efficacy and Effect on Nasopharyngeal Carriage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Epidemiology of pneumococcal serotypes and conjugate vaccine formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021

Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2802%2900068-X

7 January 2021